Dogwood Therapeutics, Stock Market Value
| DWTX Stock | 2.40 0.20 7.69% |
| Symbol | Dogwood |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dogwood Therapeutics,. If investors know Dogwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dogwood Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dogwood Therapeutics, is measured differently than its book value, which is the value of Dogwood that is recorded on the company's balance sheet. Investors also form their own opinion of Dogwood Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Dogwood Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dogwood Therapeutics,'s market value can be influenced by many factors that don't directly affect Dogwood Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dogwood Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Dogwood Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dogwood Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dogwood Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dogwood Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dogwood Therapeutics,.
| 06/04/2024 |
| 12/01/2024 |
If you would invest 0.00 in Dogwood Therapeutics, on June 4, 2024 and sell it all today you would earn a total of 0.00 from holding Dogwood Therapeutics, or generate 0.0% return on investment in Dogwood Therapeutics, over 180 days. Dogwood Therapeutics, is related to or competes with Viracta Therapeutics, Viking Therapeutics, Dyadic International, Vanda Pharmaceuticals, Virax Biolabs, and Verrica Pharmaceuticals. Dogwood Therapeutics, is entity of United States More
Dogwood Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dogwood Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dogwood Therapeutics, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 69.76 | |||
| Value At Risk | (18.49) | |||
| Potential Upside | 15.01 |
Dogwood Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dogwood Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dogwood Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Dogwood Therapeutics, historical prices to predict the future Dogwood Therapeutics,'s volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (2.25) | |||
| Treynor Ratio | (0.23) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dogwood Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dogwood Therapeutics, Backtested Returns
Dogwood Therapeutics, secures Sharpe Ratio (or Efficiency) of -0.0297, which denotes the company had a -0.0297% return per unit of risk over the last 3 months. Dogwood Therapeutics, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dogwood Therapeutics,'s Variance of 129.13, mean deviation of 7.42, and Standard Deviation of 11.36 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.5, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dogwood Therapeutics, will likely underperform. At this point, Dogwood Therapeutics, has a negative expected return of -0.34%. Please make sure to confirm Dogwood Therapeutics,'s maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Dogwood Therapeutics, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.32 |
Below average predictability
Dogwood Therapeutics, has below average predictability. Overlapping area represents the amount of predictability between Dogwood Therapeutics, time series from 4th of June 2024 to 2nd of September 2024 and 2nd of September 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dogwood Therapeutics, price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current Dogwood Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.32 | |
| Spearman Rank Test | 0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.66 |
Dogwood Therapeutics, lagged returns against current returns
Autocorrelation, which is Dogwood Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dogwood Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Dogwood Therapeutics, returns to help us make a trade decision. For example, suppose you find that Dogwood Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dogwood Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dogwood Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dogwood Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dogwood Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Dogwood Therapeutics, Lagged Returns
When evaluating Dogwood Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dogwood Therapeutics, stock have on its future price. Dogwood Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dogwood Therapeutics, autocorrelation shows the relationship between Dogwood Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Dogwood Therapeutics,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.